A Qualitative Study to Explore Patient Perspectives of Prophylactic Treatment with OnabotulinumtoxinA for Chronic Migraine

INTRODUCTION: OnabotulinumtoxinA (OBT-A) is one of the most studied prophylactic treatments for chronic migraine. Large clinical trials, and now real-world studies, continue to provide evidence to support the use of OBT-A as an effective treatment to manage chronic migraine. The objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilderman, Igor, Tallarigo, Deborah, Pugacheva-Zingerman, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586057/
https://www.ncbi.nlm.nih.gov/pubmed/34523107
http://dx.doi.org/10.1007/s40122-021-00316-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586057/
https://www.ncbi.nlm.nih.gov/pubmed/34523107
http://dx.doi.org/10.1007/s40122-021-00316-2

Ejemplares similares